Rituximab for treating inhibitors in people with inherited severe haemophilia

This review did not identify any relevant randomised controlled trials. The research evidence available was limited to case reports and case series therefore no conclusions could be drawn on the efficacy and safety of rituximab for treating inhibitors in people with haemophilia.

Source:

Cochrane Database of Systematic Reviews